Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
WAY · 10-Q filed July 29, 2026

WAY earnings analysis

What we found in WAY's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Waystar delivered an 18.1% year-over-year revenue increase to $319.674 million, driven principally by 34.5% subscription-revenue growth, while GAAP EPS increased from $0.18 to $0.21. Profitability improved materially versus last year—gross margin reached 69.4% and adjusted EBITDA margin 42.8%—but operating margin declined sequentially to 23.8% amid stepped-up R&D, G&A and an impairment. The principal new filing-specific concern is the June cybersecurity incident, although management says it involved fewer than 1% of clients, did not affect production systems, and is not currently expected to be materially adverse.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue growth remained high-teens
Q2 revenue was $319.674 million, up $49.020 million (18.1%) from $270.654 million a year earlier and about $5.7 million above the $313.874 million generated in Q1 2026. Six-month revenue increased 20.2% to $633.548 million.
Earnings increased year over year
GAAP net income rose 27.0% to $40.867 million from $32.184 million, and diluted EPS was $0.21 versus $0.18 a year ago. Non-GAAP diluted EPS was $0.43, up from $0.36 in the prior-year quarter.
Subscription and provider solutions led growth
Subscription revenue increased $45.179 million, or 34.5%, to $176.287 million, accounting for most of the $49.020 million total revenue increase. Provider-solution revenue grew 22.9% to $231.804 million, while patient-payments revenue rose 7.2% to $87.870 million.
Gross margin and adjusted EBITDA expanded
Gross margin expanded to 69.4% from 67.8% a year ago as cost of revenue rose 12.2%, below 18.1% revenue growth. Adjusted EBITDA grew 21.5% to $136.725 million and its margin improved 120 basis points to 42.8%.
Retention and large-client count remained strong
Customer monetization and enterprise-client depth progressed: net revenue retention was 108.3%, and clients generating more than $100,000 of trailing-12-month revenue increased to 1,453 from 1,268 a year ago.
Cash generation supported buybacks
The company generated $144.324 million of operating cash flow in the first six months and began deploying its $200 million repurchase authorization, buying 659,061 shares at an average $19.24 price; $187.32 million remained available at June 30.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Cybersecurity incident introduces liability risk
The sole material risk-factor update describes an early-June 2026 cybersecurity incident involving unauthorized acquisition of testing source-code copies and four inactive-data files. The affected data included PHI/PII tied to fewer than 1% of Waystar clients, and the company recorded $1.618 million of related costs in Q2; ultimate remediation, legal, reputational and insurance outcomes remain uncertain.
Sequential operating-margin compression
Operating margin was 23.8%, down 180 basis points from 25.6% in Q1 2026 and slightly below 24.0% a year ago. R&D expense rose 40.4% to $17.723 million, G&A rose 24.6% to $36.378 million, and G&A included a $1.990 million office/lease impairment.
Net revenue retention moderated
Net revenue retention declined to 108.3% from 114.6% a year earlier. Management notes both periods include benefits from elevated win rates and faster implementations following a competitor cybersecurity incident, which may limit comparability and normalization risk remains.
Operating cash flow declined and investment rose
Six-month operating cash flow fell $16.685 million, or 10.4%, to $144.324 million despite higher profit, while investing cash usage rose to $182.082 million from $61.718 million. The filing does not disclose a free-cash-flow figure or a separately quantified capex amount in the provided text.
Leverage and floating-rate exposure remain
Interest expense including related-party interest increased 7.6% to $19.646 million in Q2, principally from incremental First Lien Credit Facility borrowing for Iodine. A 100-basis-point rate change would affect six-month interest expense by approximately $7.4 million.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $30 Operating expenses $46 Left as operating profit $24
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Earnings per share
$0.21
Gross margin
69.4%
Operating margin
23.8%
Segment
Provider solutions revenue: $231.804 million, up $43.120 million (22.9%) year over year
Segment
Patient payments solutions revenue: $87.870 million, up $5.900 million (7.2%) year over year
Segment
Subscription revenue: $176.287 million, up $45.179 million (34.5%) year over year
Segment
Volume-based revenue: $142.149 million, up $3.859 million (2.8%) year over year
Guidance

What they said about what is next.

The 10-Q does not provide a quantitative revenue or EPS outlook; management’s formal FY2026 guidance was provided separately in the earnings release. MD&A states that existing unrestricted cash, expected operating cash flow and additional borrowings are expected to fund requirements for at least the next 12 months and beyond.

How we read the filing overall

The filing reads better than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · April 29, 2026
Waystar's Q1 2026 results exhibit a strong performance with revenue of $313.9 million, marking a 22.4% increase year-over-year. Net income surged by 47.9% to $43.3 million, driven by rising subscription revenues, which…
10-K · February 17, 2026
Waystar positions itself as a data- and AI-driven leader in healthcare payments with scale advantages (over 30,000 clients and processing 7.5 billion transactions) and a large addressable market (TAM $20.0 billion in…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing WAY makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever